- Home
- SEVN vs NAUT Comparison
SEVN vs NAUT Comparison
Compare SEVN & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEVN
- NAUT
- Stock Information
- Founded
- SEVN 1986
- NAUT 2016
- Country
- SEVN United States
- NAUT United States
- Employees
- SEVN N/A
- NAUT N/A
- Industry
- SEVN Real Estate Investment Trusts
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- SEVN Real Estate
- NAUT Industrials
- Exchange
- SEVN Nasdaq
- NAUT Nasdaq
- Market Cap
- SEVN 188.3M
- NAUT 188.3M
- IPO Year
- SEVN N/A
- NAUT N/A
- Fundamental
- Price
- SEVN $10.97
- NAUT $0.72
- Analyst Decision
- SEVN Strong Buy
- NAUT Hold
- Analyst Count
- SEVN 3
- NAUT 3
- Target Price
- SEVN $14.50
- NAUT $3.58
- AVG Volume (30 Days)
- SEVN 51.2K
- NAUT 182.9K
- Earning Date
- SEVN 04-28-2025
- NAUT 04-29-2025
- Dividend Yield
- SEVN 12.76%
- NAUT N/A
- EPS Growth
- SEVN N/A
- NAUT N/A
- EPS
- SEVN 1.20
- NAUT N/A
- Revenue
- SEVN $29,847,000.00
- NAUT N/A
- Revenue This Year
- SEVN $14.73
- NAUT N/A
- Revenue Next Year
- SEVN $5.39
- NAUT N/A
- P/E Ratio
- SEVN $9.22
- NAUT N/A
- Revenue Growth
- SEVN N/A
- NAUT N/A
- 52 Week Low
- SEVN $10.18
- NAUT $0.66
- 52 Week High
- SEVN $14.66
- NAUT $3.09
- Technical
- Relative Strength Index (RSI)
- SEVN 26.32
- NAUT 36.14
- Support Level
- SEVN $10.18
- NAUT $0.66
- Resistance Level
- SEVN $13.02
- NAUT $0.90
- Average True Range (ATR)
- SEVN 0.45
- NAUT 0.09
- MACD
- SEVN -0.18
- NAUT 0.01
- Stochastic Oscillator
- SEVN 27.82
- NAUT 40.00
About SEVN Seven Hills Realty Trust
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in the business of originating and investing in floating rate first mortgage loans secured by the middle market and transitional commercial real estate. Its primary objective is to balance capital preservation with generating risk-adjusted returns.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.